Add to cart 2Q21 Sales Benchmark: A Short-Term Slowdown? $99.00 Outsell’s 2Q21 sales performance benchmark indicated a strong start to 2021, but now some signs of strain are showing. This analysis explores how leaders are reacting and what their expectations are for the full year. Read more on the Outsell Leadership Community Platform: 2Q21 Sales Benchmark: A Short-Term Slowdown? Author: Ned May Date: July 27, 2021
Add to cart Biased Algorithms Risk Derailing HealthTech Advances $99.00 Negative publicity surrounding the accuracy of digital health patient treatment platforms and the algorithms that drive them may short-circuit the recent rush to invest in emerging HealthTech companies. Read more on the Outsell Leadership Community Platform: Biased Algorithms Risk Derailing HealthTech Advances Author: David Potter Date: July 26, 2021